|
63
|
258
|
1p8vC |
Crystal structure of the complex of platelet receptor gpib-alpha and alpha-thrombin at 2.6a |
|
55
|
223
|
1p2kA |
Structural consequences of accommodation of four non-cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin |
|
51
|
198
|
1p03A |
Structure analysis of specificity. alpha-lytic protease complexes with analogues of reaction intermediates |
|
53
|
234
|
1op2A |
Crystal structure of aav-sp-ii, a glycosylated snake venom serine proteinase from agkistrodon acutus |
|
54
|
198
|
1p01A |
Serine protease mechanism. structure of an inhibitory complex of alpha-lytic protease and a tightly bound peptide boronic acid |
|
56
|
223
|
1oyqA |
Trypsin inhibitor complex |
|
60
|
245
|
1owhA |
Substituted 2-naphthamidine inhibitors of urokinase |
|
59
|
254
|
1p57B |
Extracellular domain of human hepsin |
|
50
|
234
|
1op8A |
Crystal structure of human granzyme a |
|
53
|
245
|
1p2qA |
Structural consequences of accommodation of four non-cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin |
|
58
|
257
|
1oytH |
Complex of recombinant human thrombin with a designed fluorinated inhibitor |
|
83
|
299
|
1p9uA |
Coronavirus main proteinase (3clpro) structure: basis for design of anti-sars drugs |
|
52
|
198
|
1p12E |
Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters |
|
53
|
245
|
1oxgA |
Crystal structure of a complex formed between organic solvent treated bovine alpha-chymotrypsin and its autocatalytically produced highly potent 14-residue peptide at 2.2 resolution |
|
50
|
245
|
1owiA |
Substituted 2-naphthamidine inhibitors of urokinase |
|
50
|
235
|
1pfxC |
Porcine factor ixa |
|
49
|
232
|
1orfA |
The oligomeric structure of human granzyme a reveals the molecular determinants of substrate specificity |
|
62
|
215
|
1p3eA |
Structure of glu endopeptidase in complex with mpd |
|
53
|
198
|
1p09A |
Structural plasticity as a determinant of enzyme specificity. creating broadly specific proteases |
|
52
|
198
|
1p04A |
Structure analysis of specificity. alpha-lytic protease complexes with analogues of reaction intermediates |
|
53
|
223
|
1ophB |
Non-covalent complex between alpha-1-pi-pittsburgh and s195a trypsin |
|
53
|
245
|
1p2nA |
Structural consequences of accommodation of four non-cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin |
|
57
|
235
|
1p0sH |
Crystal structure of blood coagulation factor xa in complex with ecotin m84r |
|
58
|
223
|
1ox1A |
Crystal structure of the bovine trypsin complex with a synthetic 11 peptide inhibitor |
|
49
|
245
|
1owkA |
Substituted 2-naphthamidine inhibitors of urokinase |
|
74
|
300
|
1p9sA |
Coronavirus main proteinase (3clpro) structure: basis for design of anti-sars drugs |
|
59
|
223
|
1p2jA |
Structural consequences of accommodation of four non-cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin |
|
55
|
245
|
1p2oA |
Structural consequences of accommodation of four non-cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin |
|
53
|
198
|
1p10A |
Structural plasticity as a determinant of enzyme specificity. creating broadly specific proteases |
|
57
|
223
|
1ossA |
T190p streptomyces griseus trypsin in complex with benzamidine |
|
51
|
198
|
1p11E |
Crystal structures of alpha-lytic protease complexes with irreversibly bound phosphonate esters |
|
54
|
198
|
1p06A |
Structure analysis of specificity. alpha-lytic protease complexes with analogues of reaction intermediates |
|
58
|
245
|
1oweA |
Substituted 2-naphthamidine inhibitors of urokinase |
|
58
|
245
|
1owdA |
Substituted 2-naphthamidine inhibitors of urokinase |
|
60
|
234
|
1op0A |
Crystal structure of aav-sp-i, a glycosylated snake venom serine proteinase from agkistrodon acutus |
|
63
|
215
|
1p3cA |
Glutamyl endopeptidase from bacillus intermedius |
|
54
|
245
|
1p2mA |
Structural consequences of accommodation of four non-cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin |
|
52
|
198
|
1p02A |
Structure analysis of specificity. alpha-lytic protease complexes with analogues of reaction intermediates |
|
58
|
255
|
1o5eH |
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) |
|
55
|
223
|
1o3nA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
53
|
223
|
1o3kA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
55
|
223
|
1o2zA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
54
|
223
|
1o2qA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
53
|
223
|
1o2rA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
55
|
223
|
1o3lA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
54
|
223
|
1o3eA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
54
|
223
|
1o2vA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
55
|
223
|
1o2uA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
|
57
|
257
|
1o5gH |
Dissecting and designing inhibitor selectivity determinants at the s1 site using an artificial ala190 protease (ala190 upa) |
|
55
|
223
|
1o2lA |
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors |
